Literature DB >> 2771359

Chemodenervation of strabismic children. A 2- to 5-year follow-up study compared with shorter follow-up.

E H Magoon1.   

Abstract

To determine longer-term efficacy of botulinum treatment, the author examined 85 children younger than 14 years of age who had been treated from November 1982 to February 1984, comparing shorter follow-up (range, 6-24 months) with longer follow-up (range, 2-5.5 years) as of last examination before March 1988. Fifty esotropes meeting the 2-year criteria for follow-up had an average of 35 prism diopters (PD) before and 5 PD after treatment. Twelve exotropes averaged 30 and 5 PD. No long-term complications were discovered. The results are similar to the shorter follow-up and suggest that botulinum is effective in creating a 2- to 5-year stable improvement for strabismic children.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2771359

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Botulinum alignment for congenital esotropia.

Authors:  M R Ing
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  Acute and long-term effects of botulinum neurotoxin on the function and structure of developing extraocular muscles.

Authors:  Scott A Croes; Larisa M Baryshnikova; Soniya S Kaluskar; Christopher S von Bartheld
Journal:  Neurobiol Dis       Date:  2007-01-10       Impact factor: 5.996

3.  Early retreatment of infantile esotropia: comparison of reoperation and botulinum toxin.

Authors:  J Tejedor; J M Rodríguez
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

4.  Retreatment of children after surgery for acquired esotropia: reoperation versus botulinum injection.

Authors:  J Tejedor; J M Rodríguez
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

Review 5.  The role of drug treatment in children with strabismus and amblyopia.

Authors:  K I Chatzistefanou; M D Mills
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.930

6.  Botulinum toxin injection without electromyographic guidance in consecutive esotropia.

Authors:  Hee Kyung Yang; Dong Hyun Kim; Jeong-Min Hwang
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.